Tumour necrosis factor-alpha and nitric oxide mediate apoptosis by D-galactosamine in a primary culture of rat hepatocytes: Exacerbation of cell death by cocultured Kupffer cells

Canadian Journal of Gastroenterology

Volumn 16, Issue 11, 2002, Pages 791-799

  Abou Elella, Amira Mohamed Kamal ElSaid ^a   Siendones, Emilio ^a   Padillo, Javier ^a   Montero, José Luis ^a   De la Mata, Manuel ^a   Muntané Relat, Jordi ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

Cell death; Hepatocytes; Kupffer cells; Nitric oxide; Prostaglandin E1; Tumour necrosis factor alpha

Indexed keywords

DNA FRAGMENT; GALACTOSAMINE; LACTATE DEHYDROGENASE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROSTAGLANDIN E1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANIMAL CELL; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL STIMULATION; COCULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DNA DETERMINATION; ENZYME INHIBITION; ENZYME RELEASE; KUPFFER CELL; LIVER CELL; NITROGEN METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM;

EID: 0036869347     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2002/986305     Document Type: Article

References (58)

1. Urban JL, Shepard HM, Rothstein JL, Sugarman BJ, Schreiber H. Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages. Proc Natl Acad Sci USA 1986;83:5233-7.
2. Jones AL, Selby P. Tumor necrosis factor: Clinical relevance. Cancer Surv 1989;8:817-36.
3. Lehmann V, Freudenberg MA, Galanos C. Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and D-galactosamine-treated mice. J Exp Med 1987;165:657-63.
4. Beutler B, Milsark IW, Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 1985;229:869-71.
5. Karck U, Peters T, Decker K. The release of tumor necrosis factor from endotoxin-stimulated rat Kupffer cells is regulated by prostaglandin E2 and dexamethasone. J Hepatol 1988;7:352-61.
6. Quiroga J, Prieto J. Liver cytoprotection by prostaglandins. Pharmacol Therapeut 1993;58:67-91.
7. Dixit V, Chang TMS. Effects of prostaglandin E2 on brain edema and liver histopathology in a galactosamine-induced fulminant hepatic failure rat model. Biomat Artif Cells Artif Organs 1987;15:559-73.
8. Bergasa NV, Borque MJ, Wahl LM, Rabin L, Jones EA. Modulation of thioacetamide-induced hepatocellular necrosis by prostaglandins is associated with novel histologic changes. Liver 1992;12:168-74.
9. Rush BD, Wilkinson KF, Nichols NM, Ochoa R, Brunden MN, Ruwart MJ. Hepatic protection by 16, 16-dimethyl prostaglandin E2 (DMPG) against acute aflatoxin B1-induced injury in the rat. Prostaglandins 1989;37:683-93.
10. Stachura J, Tarnawski A, Ivey KJ, et al. Prostaglandin protection of carbon tetrachloride-induced liver cell necrosis in the rat. Gastroenterology 1981;81:211-7.
11. Beck PL, Mcknight GW, Kelly JK, Wallace JL, Lee SS. Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology 1993;105:1483-9.
12. Ruwart MJ, Rush BD, Snyder KF, Peters KM, Appelman HD, Henley KS. 16,16-dimethyl prostaglandin E2 delays collagen formation in nutritional injury in rat liver. Hepatology 1988;8:61-4.
13. Abecassis M, Falk JA, Makowka L, Dondzans VJ, Folk RE, Levy GA. 16, 16 dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest 1987;80:881-9.
14. Kurebayashi Y, Honda Y. Protection by 16, 16-dimethyl prostaglandin E2 and dibutyryl cyclic AMP against complement-mediated hepatic necrosis in rats. Hepatology 1991;14:545-50.
15. Sinclair SB, Greig PD, Blendis LM, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. J Clin Invest 1989;84:1063-9.
16. Sinclair SB, Levy GA. Treatment of fulminant viral hepatic failure with prostaglandin E. A preliminary report. Dig Dis Sci 1991;36:791-800.
17. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-42.
18. Geller DA, Nussler AK, Di Silvio M, et al. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes. Proc Natl Acad Sci USA 1993:90:522-6.
19. Clemens MG. Nitric oxide in liver injury. Hepatology 1999:30:1-5.
20. Szabó C, Southan GJ, Thiemermann Ch. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994;91:12472-6.
21. Wang JIH, Redmond HP, Wu QD, Bouchiers-Hayes D. Nitric oxide mediates hepatocyte injury. Am J Physiol 1998;275:G1117-26.
22. Gardner CR, Heck DE, Yang ChS, et al. Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 1998;26:748-54.
23. Vos TA, Gouw ASH, Klok PA, et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997;113:1323-33.
24. Bohlinger I, Leist M, Barsig J, Uhlig S, Tiegs G, Wendel A. Interleukin-1 and nitric oxide protects against tumor necrosis factor α-induced liver injury through distinct pathways. Hepatology 1995;22:1829-37.
25. Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994;266:G1004-10.
26. Cottart Ch-H, Do L, Blanc M-C, et al. Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology 1999;29:809-13.
27. Florquin S, Amraoui Z, Dubois Ch, Decuyper J, Goldman M. The protective role of endogenously synthesized nitric oxide in staphylococcal enterotoxin B-induced shock in mice. J Exp Med 1994;180:1153-8.
28. Zahlten RN, Hagler HK, Nejtek ME, Day CJ. Morphological characterization of Kupffer and endothelial cells of rat liver isolated by counterflow elutriation. Gastroenterology 1978;75:80-7.
29. Seglen PO. Preparation of isolated rat liver cells. Method Cell Biol 1976;13:29-83.
30. Kuiper J, Brouwer A, Knook DL, Van Berkel TJC. Kupffer and sinusoidal endothelial cells. In: Arias IM, Boyer JL, Fausto N, Jacoby WB, Schachler DA, Shafritz DA, eds. The Liver: Biology and Pathobiology, 3rd edn. New York: Raven, 1994:791-818.
31. Taffs R, Sitkovsky M. In vitro assays for mouse B and T lymphocyte function. In: Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current Protocols in Immunology. New York: Greene Publishing and Wiley-Interscience, 1991:3.16.1-3.16.8.
32. 15N]nitrate in biological fluids. Anal Biochem 1982;126:131-8.
33. Muntané J, Rodríguez FJ, Segado O, et al. TNF-α-dependent production of inducible nitric oxide is involved in PGE1 protection against acute liver injury. Gut 2000;47:553-62.
34. Quintero A, Pedraza CA, Siendones E, et al. PGE1 protection against apoptosis induced by D-galactosamine is not related to the modulation of intracellular free radical production in primary culture of rat hepatocytes. Free Radical Res 2002;36:345-55.
35. Tran-Thi TA, Phillips J, Falk H, Decker K. Toxicity of D-Galactosamine for rat hepatocytes in monolayer culture. Exp Mol Pathol 1985;42:89-116.
36. Decker K, Keppler D. Galactosamine-induced liver injury. In: Popper H, Schaffner F, eds. Progress in Liver Disease. New York: Grune and Stratton, 1972:183-96.
37. Tsutsui S, Hirasawa K, Takeda M, et al. Apoptosis of murine hepatocytes induced by high doses of Galactosamine. J Vet Med Sci 1997;59:785-90.
38. Muntané J, Montero JL, Marchal T, et al. Effect of PGE1 on TNF-α status and hepatic D-galactosamine-induced apoptosis in rats. J Gastroenterol Hepatol 1998;13:197-207.
39. El-Mofty S, Scrutton MC, Serroni A, Nicolini C1, Farber JL. Early, reversible plasma membrane injury in Galactosamine-induced liver cell death. Am J Pathol 1975;79:579-96.
40. Muntanié J, Montero JL, Lozano JM, Miranda-Vizuete A, De la Mara M, Miño G. TNF-α but not Il-1α are correlated with PGE1-dependent protection against acute D-galactosamine-induced liver injury. Can J Gastroenterol. 2000;14:175-80.
41. Mihas AA, Ceballos R, Mihas TA, Hirschowitz BI. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin. J Med 1990;21:301-11.
42. Hiraku Y, Kawanishi S. Involvement of oxidative damage and apoptosis in antitumor actions of aminosugars. Free Radical Res 1999;31:389-403.
43. Chung H-T, Pae H-O, Choi B-M, Billiar TR, Kim Y-M. Breakthroughs and views. Nitric oxide as a bioregulator of apoptosis. Biochem Biophys Res Comms 2001;282:1075-9.
44. Kim YM, Chung H-T, Simmons RL, Billiar TR. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition. J Biol Chem 2000;275:10954-61.
45. Kim Y-M, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-48.
46. Hatano E, Bennet BL, Manning AM, Qian T, Lemasters JJ, Brenner DA. NF-kB stimulates inducible nitric oxide synthase to protect mouse hepatocytes from TNF-α- and Fas-mediated apoptosis. Gastroenterology 2001;120:1251-62.
47. Saad B, Frei K, Scholl FA, Fontana A, Maier P. Hepatocyte-derived interleukin-6 and tumor-necrosis factor α mediate the lipopolysaccharide-induced acute-phase response and nitric oxide release by cultured rat hepatocytes. Eur J Biochem 1995;229:349-55.
48. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Tumor necrosis factor induces programmed cell death in mouse hepatocyte cultures. J Immunol 1994;153:1778-88.
49. McMillan JM. Galactosamine decreases nitric oxide formation in cultured rat hepatocytes: lack of involvement in cytotoxicity. J Biochem. Mol Pharmacol 1999;13:135-42.
50. McMillan JM. Galactosamine decreases nitric oxide formation in cultured rat hepatocytes: mechanism of suppression. J Biochem Mol Pharmacol 1999;13:143-8.
51. Rodríguez-Ariza A, Paine AJ. Rapid induction of NF-kB binding during liver cell isolation and culture: inhibition by L-NAME indicates a role for nitric oxide synthase. Biochem Biophys Res Comms 1999;257:145-8.
52. Lépez-García MP. Endogenous nitric oxide is responsible for the early loss of P450 in cultured hepatocytes. FEBS Lett 1998;438:145-9.
53. Kurose I, Kato S, Ishii H, et al. Nitric oxide mediates lipopolysaccharide-induced alteration of mitochondrial function in cultured hepatocytes and isolated perfused liver. Hepatology 1993;18:380-8.
54. Stadler J, Curran RD, Ochoa JB, et al. Effect of endogenous nitric oxide on mitochondrial respiration of rat hepatocytes in vitro and in vivo. Arch Surg 1991;126:186-91.
55. Billiar TR, Curran RD, West MA, Hofmann K, Simmons RL. Kupffer cell cytotoxicity to hepatocytes in coculture requires L-arginine. Arch Surg 1989;124:1416-21.
56. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989;169:1467-72.
57. Kurose I, Higuchi H, Yonei Y, et al. Rat Kupffer cell-derived nitric oxide suppresses proliferation and induces apoptosis of syngeneic hepatoma cells. Gastroenterology 1996;111:1058-70.
58. McMillan JM, Jollow DJ. Macrophage enhencement of galactosamine hepatotoxicity using a rat hepatocyte culture system. Res Commun Mol Pathol Pharmacol 1995;88:327-38.